HYDERABAD, India, June 30, 2026 /PRNewswire/ -- Shantha Biologics today announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
Morepen updates on ₹825 crore CDMO mandate; completes first commercial batch
Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech…
Aurobindo Pharma launches TheraNym, a biologics contract manufacturing organization, with MSD as its anchor customer in Hyderabad.
Novo Nordisk is leveraging Artificial Intelligence to significantly speed up new drug launches. The company expects to cut down…
A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a standoff.…
Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection…
Aurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic…
